Drug Search Results
More Filters [+]

Titanium dioxide

Alternative Names: titanium dioxide, ti-02, ti02, ti 02, anthelios 20, anthelios 40
Latest Update: 2024-11-12
Latest Update Note: Clinical Trial Update

Product Description

Titanium dioxide (TiO2) is a natural oxide of the element titanium with low toxicity, and negligible biological effects.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/26996620/)

Mechanisms of Action: UV Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous,Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Bangladesh | Belgium | Brazil | Canada | Chile | Croatia | Denmark | Ecuador | France | Hong Kong | India | Ireland | Israel | Italy | Malta | Morocco | New Zealand | Norway | Portugal | Sweden | Taiwan | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Orfagen
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Titanium dioxide

Countries in Clinic: Egypt

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Dentin Sensitivity

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Fadia Ali El-Sayed Shosha

P1

Completed

Dentin Sensitivity

2023-03-15

21%

Recent News Events